BCAL Diagnostics Limited
BCAL Diagnostics Limited (BDX.AX) Company Profile & Overview
Explore BCAL Diagnostics Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
BCAL Diagnostics Limited (BDX.AX) Company Profile & Overview
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.